ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinoma https://www.biorxiv.org/content/10.1101/2023.07.24.550274v1?med=mas
ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinoma https://www.biorxiv.org/content/10.1101/2023.07.24.550274v1?med=mas